{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Prostate : Questions médicales les plus fréquentes",
"headline": "Prostate : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Prostate : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Prostate"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glandes exocrines",
"url": "https://questionsmedicales.fr/mesh/D005088",
"about": {
"@type": "MedicalCondition",
"name": "Glandes exocrines",
"code": {
"@type": "MedicalCode",
"code": "D005088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A10.336"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Prostate",
"alternateName": "Prostate",
"code": {
"@type": "MedicalCode",
"code": "D011467",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "A A Kamalov",
"url": "https://questionsmedicales.fr/author/A%20A%20Kamalov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "L M Samokhodskaya",
"url": "https://questionsmedicales.fr/author/L%20M%20Samokhodskaya",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "V K Karpov",
"url": "https://questionsmedicales.fr/author/V%20K%20Karpov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "D A Okhobotov",
"url": "https://questionsmedicales.fr/author/D%20A%20Okhobotov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "V N Mamedov",
"url": "https://questionsmedicales.fr/author/V%20N%20Mamedov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37378940",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2023.24.6.2089"
}
},
{
"@type": "ScholarlyArticle",
"name": "Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/36967102",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cgh.2023.03.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.",
"datePublished": "2023-02-18",
"url": "https://questionsmedicales.fr/article/36804602",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36495927",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ypmed.2022.107384"
}
},
{
"@type": "ScholarlyArticle",
"name": "A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA.",
"datePublished": "2022-10-06",
"url": "https://questionsmedicales.fr/article/36203138",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12876-022-02512-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tissus",
"item": "https://questionsmedicales.fr/mesh/D014024"
},
{
"@type": "ListItem",
"position": 3,
"name": "Glandes exocrines",
"item": "https://questionsmedicales.fr/mesh/D005088"
},
{
"@type": "ListItem",
"position": 4,
"name": "Prostate",
"item": "https://questionsmedicales.fr/mesh/D011467"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Prostate - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Prostate",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Prostate",
"description": "Comment diagnostiquer un cancer de la prostate ?\nQuels tests sont utilisés pour évaluer la prostate ?\nQuand faut-il faire un dépistage de la prostate ?\nQuels symptômes indiquent un problème de prostate ?\nQuel rôle joue l'examen rectal ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=8#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Prostate",
"description": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?\nLa douleur pelvienne est-elle un symptôme courant ?\nComment reconnaître une infection de la prostate ?\nLes problèmes d'érection sont-ils liés à la prostate ?\nLe sang dans les urines est-il alarmant ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=8#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Prostate",
"description": "Peut-on prévenir le cancer de la prostate ?\nQuel rôle joue l'alimentation dans la prévention ?\nL'exercice physique aide-t-il à prévenir les problèmes de prostate ?\nLe tabagisme influence-t-il le risque de cancer de la prostate ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=8#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Prostate",
"description": "Quels traitements existent pour le cancer de la prostate ?\nComment traiter l'hypertrophie bénigne de la prostate ?\nQu'est-ce que l'hormonothérapie ?\nLa radiothérapie est-elle efficace ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=8#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Prostate",
"description": "Quelles sont les complications du cancer de la prostate ?\nLes traitements peuvent-ils causer des complications ?\nQuelles sont les conséquences d'une prostatite non traitée ?\nLe cancer de la prostate peut-il affecter d'autres organes ?\nComment gérer les complications après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=8#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Prostate",
"description": "Quels sont les principaux facteurs de risque du cancer de la prostate ?\nL'alimentation influence-t-elle le risque de cancer de la prostate ?\nLe surpoids est-il un facteur de risque ?\nLe niveau d'activité physique joue-t-il un rôle ?\nLes antécédents familiaux augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=8#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer de la prostate ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par un examen rectal, un dosage du PSA et une biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la prostate ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, l'IRM et le dosage du PSA."
}
},
{
"@type": "Question",
"name": "Quand faut-il faire un dépistage de la prostate ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage est recommandé à partir de 50 ans, ou 45 ans pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de prostate ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à uriner, des douleurs pelviennes ou du sang dans les urines peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'examen rectal ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen rectal permet de détecter des anomalies de la prostate, comme des nodules."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mictions fréquentes, un jet urinaire faible et des urgences."
}
},
{
"@type": "Question",
"name": "La douleur pelvienne est-elle un symptôme courant ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur pelvienne peut être un symptôme de prostatite ou de cancer."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection de la prostate ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections se manifestent par des douleurs, des mictions douloureuses et de la fièvre."
}
},
{
"@type": "Question",
"name": "Les problèmes d'érection sont-ils liés à la prostate ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles érectiles peuvent être liés à des problèmes de prostate ou à des traitements."
}
},
{
"@type": "Question",
"name": "Le sang dans les urines est-il alarmant ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de sang dans les urines nécessite une évaluation médicale immédiate."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le cancer de la prostate ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits, légumes et oméga-3 peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir les problèmes de prostate ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut contribuer à maintenir une prostate en bonne santé."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque de cancer de la prostate ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de développer un cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des problèmes de prostate."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour le cancer de la prostate ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et l'hormonothérapie."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hypertrophie bénigne de la prostate ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comprennent des médicaments, des thérapies minimales invasives et la chirurgie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hormonothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hormonothérapie vise à réduire les niveaux d'hormones qui stimulent la croissance du cancer."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie est un traitement efficace pour le cancer localisé de la prostate."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des troubles urinaires, des dysfonctionnements érectiles et de la fatigue."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du cancer de la prostate ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure la propagation du cancer, des douleurs chroniques et des problèmes urinaires."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils causer des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires comme des troubles urinaires et érectiles."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une prostatite non traitée ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prostatite non traitée peut entraîner des infections récurrentes et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Le cancer de la prostate peut-il affecter d'autres organes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le cancer peut se propager aux os, aux ganglions lymphatiques et à d'autres organes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications après traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications peut inclure des médicaments, des thérapies physiques et un suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du cancer de la prostate ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et l'origine ethnique."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de cancer de la prostate ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses animales peut augmenter le risque de cancer."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids et l'obésité sont associés à un risque accru de cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Le niveau d'activité physique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque de développer un cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir un parent proche atteint de cancer de la prostate augmente le risque personnel."
}
}
]
}
]
}
Prostate cancer is one of the most widespread cancers in the world. Early diagnosis is the most important factor in treatment efficiency. Furthermore, new methods for early diagnosis and treatment pla...
Anti- PSCA antibodies were purified and conjugated to super magnetic oxide nanoparticles (SPION). Then, iron staining on prostate adenocarcinoma tissues was performed. At the same time, immunohistoche...
In adenocarcinoma tissues with iron staining, many blue spots are seen compared to benign tissues, and the number of these spots increases with increasing tumor grade....
These findings indicate the characteristic of iron staining as a conjugate antibody to iron can be an appropriate approach to specific staining of tumor markers in cancer tissues and can be used to di...
Early detection of pancreatic cancer (PaC) can drastically improve survival rates. Approximately 25% of subjects with PaC have type 2 diabetes diagnosed within 3 years prior to the PaC diagnosis, sugg...
Blood was collected from 132 subjects with PaC and 528 noncancer subjects to generate epigenomic and genomic feature sets yielding a predictive PaC signal algorithm. The algorithm was validated in a b...
5hmC differential profiling and additional genomic features enabled the development of a machine learning algorithm capable of distinguishing subjects with PaC from noncancer subjects with high specif...
The PaC detection test showed robust early-stage detection of PaC signal in the studied cohorts with varying type 2 diabetes status. This assay merits further clinical validation for the early detecti...
Pancreatic cancer usually results in poor survival with limited options for treatment, as most affected individuals present with advanced disease. Early detection of preinvasive pancreatic neoplasia a...
Disparities in cancer screening and outcomes based on factors such as sex, socioeconomic status, and race and ethnicity in the United States are well documented. A blood-based multi-cancer early detec...
ColoDefense1.0 assay has demonstrated its excellent sensitivity and specificity for early detection of colorectal cancer (CRC) by detecting the methylation levels of SDC2 and SEPT9, while exhibited li...
A total 529 stool specimens were collected, and 244 CRC patients, 34 patients with advanced adenomas (AA), 64 with small polyps (SP) and 187 control subjects were divided in training and validation co...
The stool DNA quantity stored in preservative buffer at 37 °C up to 7 days exhibited no significant decrease. In the training cohort, when the number of replicates reduced from 3 to 1, the overall per...
The simplified ColoDefense test maintained the overall performance while reduced the number of PCR reactions to 1/3, and provided an effective and convenient tool to detect early CRC and precancerous ...
Prognosis of breast cancer patients has been improved along with the progress in cancer therapies. However, cancer therapeutics-related cardiac dysfunction (CTRCD) has been an emerging issue. For earl...
We prospectively enrolled 83 consecutive chemotherapy-naïve female patients with breast cancer (mean age, 56 ± 13 yrs.) between 2017 and 2020. CTRCD was defined based on echocardiography as left ventr...
A total of 164 CMRs were performed in 83 patients. LVEF and GLS were significantly decreased after chemotherapy (LVEF, from 71.2 ± 4.4 to 67.6 ± 5.8%; GLS, from -27.9 ± 3.9 to -24.7 ± 3.5%, respective...
These results indicate that CMR is useful to detect chemotherapy-related myocardial damage and predict for the development of CTRCD in breast cancer patients....
The second leading cause of lung cancer is air pollution. Air pollution and smoking are synergistic. Air pollution can worsen lung cancer survival....
The Early Detection and Screening Committee of the International Association for the Study of Lung Cancer formed a working group to better understand issues in air pollution and lung cancer. These inc...
The number of estimated attributable lung cancer deaths has increased by nearly 30% since 2007 as smoking has decreased and air pollution has increased. In 2013, the International Agency for Research ...
Worldwide air pollution levels vary widely, and the exposed populations also differ. Advocacy to lower sources of exposure is important. Health care can lower its environmental footprint, becoming mor...
The rising incidence and mortality of early-onset colorectal cancer (EOCRC) emphasize the urgent need for effective non-invasive screening. Circulating microRNAs (miRNAs) have emerged as promising bio...
Cell-free DNA (cfDNA) sequencing has demonstrated great potential for early cancer detection. However, most large-scale studies have focused only on either targeted methylation sites or whole-genome s...
Colorectal cancer (CRC) remains a significant global health challenge, with approximately 1.9 million new cases and 930,000 deaths reported in 2020. The highest incidence rates are observed in Austral...